Serratanine

Catalog No. :
ACCWHC786
CAS No. :
71384-23-1
Molecular Formula :
C30H49N3O
Molecular Weight :
467.74

IUPAC Name:1-(5-((9,12-dimethyl-3,4,4a,5,6,6a,7,8,9,10,10a,11-dodecahydro-2H-7,5-(epiminomethano)benzo[5,6]cyclohepta[1,2-b]pyridin-2-yl)methyl)-7-methyloctahydroquinolin-1(2H)-yl)ethan-1-one

Serratanine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameSerratanine
IUPAC Name1-(5-((9,12-dimethyl-3,4,4a,5,6,6a,7,8,9,10,10a,11-dodecahydro-2H-7,5-(epiminomethano)benzo[5,6]cyclohepta[1,2-b]pyridin-2-yl)methyl)-7-methyloctahydroquinolin-1(2H)-yl)ethan-1-one
Molecular FormulaC30H49N3O
Molecular Weight467.74
SMILESCC(=O)N1CCCC2C(CC3CCC4C(=N3)CC3CC(C)CC5C3CC4CN5C)CC(C)CC21
InChI KeyZGALAVFQYJOLRQ-UHFFFAOYSA-N
SynonymSerratanine;Decahydro-1-acetyl-7-methyl-5-[[2,3,4,4a,6,6a,7,8,9,10,10a,11-dodecahydro-9,12-dimethyl-7,5-(iminomethano)-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-2-yl]methyl]quinoline;Lucidine B;Quinoline, 1-acetyl-5-[[(2S,4aR,5S,6aR,7S,9R,10aS)-2,3,4,4a,6,6a,7,8,9,10,10a,11-dodecahydro-9,12-dimethyl-7,5-(iminomethano)-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-2-yl]methyl]decahydro-7-methyl-, (4aS,5R,7S,8aR)- (9CI)
CAS No.71384-23-1

Synthetic Route by SureRoute

1. ACCWHC786 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCWHC786 route product structure diagram
    ACCWHC78671384-23-1
Inquiry

2. ACCWHC786 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCWHC786 route product structure diagram
    ACCWHC78671384-23-1
Inquiry

Comments (0)